Aspirin‑arg‑gly‑asp‑val conjugate, its synthesis, nanostructure and application as drug delivery system

An arg-gly-asp-val, -arg-gly-asp-val technology, applied in the direction of non-active ingredients of polymer compounds, medical preparations containing active ingredients, drug combinations, etc.

Inactive Publication Date: 2017-11-17
CAPITAL UNIVERSITY OF MEDICAL SCIENCES
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the interaction of integrins with RGD sequence peptides has been widely used to prepare macromolecular drug carriers, no studies have used a single RGD tetrapeptide for direct drug delivery.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Aspirin‑arg‑gly‑asp‑val conjugate, its synthesis, nanostructure and application as drug delivery system
  • Aspirin‑arg‑gly‑asp‑val conjugate, its synthesis, nanostructure and application as drug delivery system
  • Aspirin‑arg‑gly‑asp‑val conjugate, its synthesis, nanostructure and application as drug delivery system

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Embodiment 1 prepares Boc-Arg (NO 2 )-Gly-OBzl

[0033] 10.0g (31.3mmol) Boc-Arg (NO 2 ) was dissolved in 100ml of anhydrous tetrahydrofuran (THF), cooled in an ice bath, and 4.3g (31.3mmol) of N-hydroxybenzotriazole (HOBt) and 6.4g (31.3mmol) of dicyclohexylcarbonyldi imine (DCC), the reaction solution was stirred under ice bath for 10 min. Add 10.6g (31.3mmol) Tos·Gly-OBzl and 3.5g (31.3mmol) N-methylmorpholine (NMM), and stir at room temperature for 24h. The reaction mixture was filtered to remove dicyclohexylurea (DCU). The filtrate was concentrated under reduced pressure, and the residue was dissolved in 150 ml of ethyl acetate. The resulting solution was sequentially washed with 5% NaHCO 3 Washing with aqueous solution, washing with saturated NaCl aqueous solution, 5% KHSO 4 Washing with aqueous solution and saturated NaCl aqueous solution. Anhydrous Na for organic phase 2 SO 4 After drying and filtering, the filtrate was concentrated to dryness under red...

Embodiment 2

[0034] Embodiment 2 prepares Boc-Arg (NO 2 )-Gly

[0035] 11.85g (25.4mmol) Boc-Arg (NO 2 )-Gly-OBzl was dissolved in 50ml of methanol, cooled in an ice bath, 12ml of sodium hydroxide-methanol solution (1M) was added, stirred for 1 hour, the reaction solution was neutralized with 2M hydrochloric acid to pH=7, concentrated under reduced pressure to remove methanol, and the remaining The product was acidified with 2M hydrochloric acid to pH=2, and concentrated under reduced pressure to remove water. The residue was dissolved with 100 ml of ethyl acetate. The resulting solution was washed with saturated NaCl aqueous solution. Anhydrous Na for organic phase 2 SO 4 Dry, filter, and concentrate the filtrate to dryness under reduced pressure. The residue was triturated with a small amount of petroleum ether to obtain 8.9 g (93%) of the title compound, which was directly cast into the next reaction. ESI-MS(m / e): 377[M-H] - .

Embodiment 3

[0036] Example 3 Preparation of Boc-Asp(OBzl)-Val-OBzl

[0037]According to the method of Example 1, 10.7 g (89%) of the title compound was obtained as an oil from 7.7 g (23.7 mmol) of Boc-Asp (OBzl) and 9.0 g (23.7 mmol) of Tos.Val-OBzl. ESI-MS(m / e): 513[M+H] + .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to view more

Abstract

Aspirin‑Arg‑Gly‑Asp‑Val conjugate, its synthesis, nanostructure and application as a drug delivery system. The invention discloses a novel aspirin-Arg-Gly-Asp-Val (A-RGDV) conjugate, its preparation method and its application as an antithrombotic agent. A-RGDV is characterized in that it can be selectively transported in the blood as nanoparticles, and after reaching the site of thrombus formation, it interacts with the GPIIb / IIIa receptors on the surface of activated platelets to release aspirin. Therefore, A‑RGDV is a targeted drug delivery system for aspirin. A‑RGDV has strong antithrombotic activity and has good clinical application prospects. The following is the structural formula of A‑RGDV. .

Description

technical field [0001] The present invention relates to a novel aspirin-Arg-Gly-Asp-Val (A-RGDV) conjugate, its preparation method and its application as an antithrombotic agent. A-RGDV is characterized in that it can be selectively transported in the form of nanoparticles in the blood, and after reaching the site of thrombus formation, it interacts with the GPIIb / IIIa receptors on the surface of activated platelets to release aspirin. Therefore, A-RGDV is a targeted drug delivery system for aspirin. A-RGDV has strong antithrombotic activity and has good clinical application prospects. The invention belongs to the field of biomedicine. The following is the structural formula of A-RGDV. [0002] Background technique [0003] Aspirin has been widely used clinically for more than a century to treat acute inflammation, pain, cardiovascular disease, stroke, pregnancy complications, cancer, diabetes, and Alzheimer's disease, demonstrating its remarkable efficacy. For differ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07K5/11C07K1/06C07K1/02A61K47/42A61K31/616A61P7/02
Inventor 彭师奇赵明吴建辉王玉记马海萍
Owner CAPITAL UNIVERSITY OF MEDICAL SCIENCES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap